Norris Medicines has informed that the meeting of the Board of Directors of the Company is scheduled on 28/06/2021, to consider and approve Audited Financial Results of the Company for the Quarter and year ended 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.